J R Stanley
Title and authors | Publication | Year |
---|---|---|
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Kridin K, Mruwat N, Ludwig RJ |
2022 | |
Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus
BC Bozca, A Bilgiç, S Uzun |
Journal of Dermatological Treatment | 2021 |
Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies
W Zhao, J Wang, H Zhu, M Pan |
Clinical Reviews in Allergy & Immunology | 2021 |
Treatment of Pemphigus with Rituximab: Real-Life Experience in a Cohort of 117 Patients in Israel
A Nosrati, E Hodak, T Mimouni, M Oren-Shabtai, A Levi, YA Leshem, D Mimouni |
Dermatology | 2021 |
Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab
SM Bhatia, RD Streilein, RP Hall, J Reddy |
PloS one | 2020 |
Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
ML Fichtner, R Jiang, A Bourke, RJ Nowak, KC OConnor |
Frontiers in immunology | 2020 |
Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first‐line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial
V Hébert, T Vermeulin, L Tanguy, B Tedbirt, C Mignard, J Bénichou, P Joly |
British Journal of Dermatology | 2020 |
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial
C Mignard, M Maho-Vaillant, ML Golinski, P Balayé, C Prost-Squarcioni, E Houivet, S Calbo, B Labeille, C Picard-Dahan, MP Konstantinou, G Chaby, MA Richard, JD Bouaziz, S Duvert-Lehembre, E Delaporte, P Bernard, F Caux, M Alexandre, S Ingen-Housz-Oro, P Vabres, G Quereux, A Dupuy, S Debarbieux, M Avenel-Audran, M DIncan, C Bédane, N Bénéton, D Jullien, N Dupin, L Misery, L Machet, M Beylot-Barry, O Dereure, B Sassolas, J Benichou, P Joly, V Hébert |
JAMA DERMATOL | 2020 |
Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single-center retrospective study
F Li, Y Wu, W Bian, L Huang, X Zhu, X Chen, M Wang |
Annals of clinical microbiology and antimicrobials | 2020 |
Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience
I Snast, L Spitzer, E Hodak, A Levi, D Mimouni, YA Leshem |
Dermatology | 2020 |
Ocular manifestations and management of autoimmune bullous diseases
S Feizi, D Roshandel |
Journal of Ophthalmic and Vision Research | 2019 |
Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen
V Hébert, M Petit, M Maho-Vaillant, ML Golinski, G Riou, C Derambure, O Boyer, P Joly, S Calbo |
Frontiers in immunology | 2019 |
Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases’ patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires
MA Saleh, I Zaraa, N Doss, NA Saleh, DF Murrell |
Anais Brasileiros de Dermatologia | 2019 |
Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse
D Giusti, G Gatouillat, SL Jan, J Plée, P Bernard, F Antonicelli, BN Pham |
Frontiers in immunology | 2018 |
Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients
Y Kurihara, J Yamagami, T Funakoshi, M Ishii, J Miyamoto, Y Fujio, R Kakuta, A Tanikawa, Y Aoyama, K Iwatsuki, N Ishii, T Hashimoto, W Nishie, H Shimizu, K Kouyama, M Amagai |
The Journal of Dermatology | 2018 |
Investigation of the predisposing factor of pemphigus and its clinical subtype through a genome-wide association and next generation sequence analysis
Y Sun, H Liu, B Yang, C Wang, JN Foo, F Bao, A Irwanto, G Yu, X Fu, Z Wang, J You, J Liu, G Zhou, J Liu, F Zhang |
Journal of the European Academy of Dermatology and Venereology | 2018 |
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
P Joly, M Maho-Vaillant, C Prost-Squarcioni, V Hebert, E Houivet, S Calbo, F Caillot, ML Golinski, B Labeille, C Picard-Dahan, C Paul, MA Richard, JD Bouaziz, S Duvert-Lehembre, P Bernard, F Caux, M Alexandre, S Ingen-Housz-Oro, P Vabres, E Delaporte, G Quereux, A Dupuy, S Debarbieux, M Avenel-Audran, M D'Incan, C Bedane, N Bénéton, D Jullien, N Dupin, L Misery, L Machet, M Beylot-Barry, O Dereure, B Sassolas, T Vermeulin, J Benichou, P Musette |
The Lancet | 2017 |
Rituximab in pemphigus
V Hebert, P Joly |
Immunotherapy | 2017 |
Serum autoantibodies against epithelial cell adhesion molecules as disease biomarkers of eosinophilic esophagitis
ES Dellon, L Lin, R Beitia, TP Moran, Y Qian |
Cell | 2017 |
Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases
S Yoshiji, T Murakami, S Harashima, R Ko, R Kashima, D Yabe, M Ogura, K Doi, N Inagaki |
Journal of Diabetes Investigation | 2017 |
Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment
P Bernard, F Antonicelli |
American Journal of Clinical Dermatology | 2017 |
Augenbeteiligung beim Pemphigus vulgaris - retrospektive Studie an einer großen spanischen Kohorte: Augenbeteiligung beim Pemphigus vulgaris
A España, P Iranzo, J Herrero-González, JM Mascaro, R Suárez |
Journal der Deutschen Dermatologischen Gesellschaft | 2017 |
Ocular involvement in pemphigus vulgaris - a retrospective study of a large Spanish cohort: Ocular involvement in pemphigus vulgaris
A España, P Iranzo, J Herrero-González, JM Mascaro, R Suárez |
Journal der Deutschen Dermatologischen Gesellschaft | 2017 |
Autoantibodies to desmogleins 1 and 3 in patients with lichen planus
L Vahide, H Zahra, G Forugh, S Nazi |
Archives of Dermatological Research | 2017 |
Pemphigus : vers une réduction drastique de la corticothérapie grâce au rituximab
P Joly |
Annales de Dermatologie et de Vénéréologie | 2017 |
Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid
K Izumi, W Nishie, Y Mai, M Wada, K Natsuga, H Ujiie, H Iwata, J Yamagami, H Shimizu |
Journal of Investigative Dermatology | 2016 |
IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?
H Ujiie |
Journal of Dermatological Science | 2015 |
Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin
W Nishie, K Natsuga, H Iwata, K Izumi, H Ujiie, E Toyonaga, H Hata, H Nakamura, H Shimizu |
The American Journal of Pathology | 2015 |
Update on the pathogenesis of bullous pemphigoid: An autoantibody-mediated blistering disease targeting collagen XVII
W Nishie |
Journal of Dermatological Science | 2014 |
Opportunistic infections in patients with pemphigus
YA Leshem, M Gdalevich, M Ziv, M David, E Hodak, D Mimouni |
Journal of the American Academy of Dermatology | 2014 |
Susceptibility loci revealed for bovine respiratory disease complex in pre-weaned holstein calves
HL Neibergs, CM Seabury, AJ Wojtowicz, Z Wang, E Scraggs, JN Kiser, M Neupane, JE Womack, A Eenennaam, G Hagevoort, TW Lehenbauer, S Aly, J Davis, JF Taylor |
BMC Genomics | 2014 |
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
N Colliou, D Picard, F Caillot, S Calbo, SL Corre, A Lim, B Lemercier, BL Mauff, M Maho-Vaillant, S Jacquot, C Bedane, P Bernard, F Caux, C Prost, E Delaporte, MS Doutre, B Dreno, N Franck, S Ingen-Housz-Oro, O Chosidow, C Pauwels, C Picard, JC Roujeau, M Sigal, E Tancrede-Bohin, I Templier, R Eming, M Hertl, M D'Incan, P Joly, P Musette |
Science Translational Medicine | 2013 |
Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase
A España, T Mòdol, MP Gil, MJ López-Zabalza |
Experimental Dermatology | 2013 |
Transition phénotypique d’un pemphigus vulgaire en pemphigus superficiel
C Lévy-Sitbon, Z Reguiaï, A Durlach, AL Goeldel, F Grange, P Bernard |
Annales de Dermatologie et de Vénéréologie | 2013 |
A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab
YA Leshem, M David, E Hodak, DA Waitman, D Vardy, M Israeli, M Eskin-Schwartz, R Bergman, D Mimouni |
Archives of Dermatological Research | 2013 |
Rituximab treatment of severe pemphigus: Long-term results including immunologic follow-up
Z Reguiai, T Tabary, M Maizières, P Bernard |
Journal of the American Academy of Dermatology | 2012 |
Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris : FAK in pemphigus vulgaris
MP Gil, T Modol, A España, MJ López-Zabalza |
Experimental Dermatology | 2012 |
Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients
YA Leshem, E Hodak, M David, GJ Anhalt, D Mimouni |
Journal of the American Academy of Dermatology | 2012 |
Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination: Pemphigus vulgaris and endoscopic examination
S Fernández, A España, M Navedo, L Barona |
British Journal of Dermatology | 2012 |
Anti-Skin Specific Autoantibodies Detected by a New Immunofluorescence Multiplex Biochip Method in Patients with Autoimmune Bullous Diseases
M Tampoia, A Zucano, D Villalta, A Antico, N Bizzaro |
Dermatology | 2012 |
Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris
T Hata, K Nishifuji, K Shimoda, T Sasaki, T Yamada, T Nishikawa, S Koyasu, M Amagai |
Journal of Dermatological Science | 2011 |
Homologous regions of heavy chain complementarity determining region 3 (H-CDR3) of pemphigus antibodies cause pathogenicity
Jun Yamagami, Aimee Payne, Stephen Kacir, Ken Ishii, Donald Siegel, John R. Stanley |
Journal of Clinical Investigation | 2010 |
Autoimmune Bullous Dermatoses in the Elderly: An Update on Pathophysiology, Diagnosis and Management
DF Mutasim |
Drugs & Aging | 2010 |
Autoimmune Bullous Dermatoses in the Elderly
DF Mutasim |
Drugs & Aging | 2010 |
Coagulation activation in autoimmune bullous diseases
AV Marzano, A Tedeschi, D Spinelli, D Fanoni, C Crosti, M Cugno |
Clinical & Experimental Immunology | 2009 |
An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris
M Pretel, A España, M Marquina, B Pelacho, JM López-Picazo, MJ López-Zabalza |
Experimental Dermatology | 2009 |
Netter's Internal Medicine
DS Rubenstein, LA Diaz |
Netter's Internal Medicine | 2009 |
Fortschritte der praktischen Dermatologie und Venerologie
T Ruzicka, H Wolff, P Thomas, J Prinz |
2009 | |
Life-Threatening Dermatoses and Emergencies in Dermatology
J Revuz, JC Roujeau, FA Kerdel, L Valeyrie-Allanore |
2009 | |
Diagnosis of Aging Skin Diseases
RA Norman |
2008 | |
Therapy of autoimmune bullous diseases
DF Mutasim |
Therapeutics and Clinical Risk Management | 2007 |
Ear, nose and throat manifestations in pemphigus vulgaris
A España, S Fernández, J Olmo, M Marquina, M Pretel, D Ruba, A Sánchez-Ibarrola |
British Journal of Dermatology | 2007 |
A Single Cycle of Rituximab for the Treatment of Severe Pemphigus
P Joly, H Mouquet, JC Roujeau, M D'Incan, D Gilbert, S Jacquot, ML Gougeon, C Bedane, R Muller, B Dreno, MS Doutre, E Delaporte, C Pauwels, N Franck, F Caux, C Picard, E Tancrede-Bohin, P Bernard, F Tron, M Hertl, P Musette |
New England Journal of Medicine | 2007 |
T cell control in autoimmune bullous skin disorders
M Hertl, R Eming, C Veldman |
Journal of Clinical Investigation | 2006 |
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just ‘witnesses of disease'?
R Paus, M Amagai, AR Ahmed, Y Kitajima, JC Bystryn, Y Milner, R Gniadecki, M Hertl, C Pincelli, M Fridkis-Hareli, Y Aoyama, M Frušić-Zlotkin, E Müller, M David, D Mimouni, D Vind-Kezunovic, B Michel, M Mahoney, S Grando |
Experimental Dermatology | 2006 |
Establishment of the Mouse Model by Rabbit Antiserum Specific to EC1-2 or EC3-4 Epitopes for Studying the Pathogenesis of Pemphigus Vulgaris
M Pan, X Zhao, F Xue, W Li, J Zheng |
Immunological Investigations | 2006 |
Interferon-gamma down-regulates expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1) in epidermal keratinocytes via novel chimeric sequences of ISRE and GAS
T Kaneko, K Tamai, Y Matsuzaki, T Yamazaki, H Nakano, A Kon, I Hashimoto, K Hanada, Y Kaneda, J Uitto |
Experimental Dermatology | 2006 |
Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid
M Yoshida, T Hamada, M Amagai, K Hashimoto, R Uehara, K Yamaguchi, K Imamura, E Okamoto, S Yasumoto, T Hashimoto |
Journal of Dermatological Science | 2006 |
Commentary 3
M Hertl |
Experimental Dermatology | 2006 |
Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis—possible involvement of the EGF receptor
M Frušić-Zlotkin, D Raichenberg, X Wang, M Frušić-Zlotkin, D Raichenberg, X Wang, M David, B Michel, Y Milner |
Autoimmunity | 2006 |
Dermatologie und Venerologie
O Braun-Falco, G Plewig, HH Wolff, WH Burgdorf, M Landthaler |
2005 | |
Autoimmune Diseases of the Skin
M Hertl |
2005 | |
T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals
CM Veldman, KL Gebhard, W Uter, R Wassmuth, J Grötzinger, E Schultz, M Hertl |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Environmental Risk Factors in Endemic Pemphigus Foliaceus (Fogo Selvagem)
V Aoki, RC Millikan, EA Rivitti, G Hans-Filho, DP Eaton, SJ Warren, N Li, J Hilario-Vargas, RG Hoffmann, LA Diaz |
Journal of Investigative Dermatology Symposium Proceedings | 2004 |
Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases
G D'Agosto, A Latini, M Carducci, A Mastroianni, A Vento, PC Fei |
Clinical and diagnostic laboratory immunology | 2004 |
In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades
I Sanchez-Carpintero, A Espana, B Pelacho, NL Moratalla, DS Rubenstein, LA Diaz, MJ Lopez-Zabalza |
British Journal of Dermatology | 2004 |
Management of autoimmune bullous diseases: Pharmacology and therapeutics
DF Mutasim |
Journal of the American Academy of Dermatology | 2004 |
Penfigoide gestacional: estudio de 9 casos
S Belmontea, SP González-Rodrígueza, CM Simóna, A Cuboa, LM Jiménez-Losaa, MA Ruiza, JL Lancharesa, LC Tejerizo-Lópeza, A Tejerizo-Garcíab |
Clínica e Investigación en Ginecología y Obstetricia | 2004 |
Keratinocyte Responsive Element 3: Analysis of a Keratinocyte-specific Regulatory Sequence in the 230-kDa Bullous Pemphigoid Antigen Gene Promoter
Y Matsuzaki, K Tamai, A Kon, D Sawamura, J Uitto, I Hashimoto |
Journal of Investigative Dermatology | 2003 |
Autoimmune Bullous Dermatoses in the Elderly: Diagnosis and Management
DF Mutasim |
Drugs & Aging | 2003 |
Tunisian endemic pemphigus foliaceus is associated with desmoglein 1 gene polymorphism
MB Ayed, P Martel, M Zitouni, D Gilbert, H Turki, M Mokni, AB Osman, MR Kamoun, A Zahaf, S Makni, H Masmoudi, F Tron |
Genes and Immunity | 2002 |
Paraneoplastic Pemphigus Sera React Strongly with Multiple Epitopes on the Various Regions of Envoplakin and Periplakin, Except for the C-Terminal Homologous Domain of Periplakin
Y Nagata, T Karashima, FM Watt, W Salmhofer, T Kanzaki, T Hashimoto |
Journal of Investigative Dermatology | 2001 |
A possible role of catenin dyslocalization in pemphigus vulgaris pathogenesis
LL Muzio, G Pannone, S Staibano, MD Mignogna, C Rubini, E Ruocco, GD Rosa, JJ Sciubba |
Journal of Cutaneous Pathology | 2001 |
Immunopathology of paraneoplastic pemphigus
T Hashimoto |
Clinics in Dermatology | 2001 |
Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule
T Hamada, Y Nagata, M Tomita, W Salmhofer, T Hashimoto |
Experimental Dermatology | 2001 |
General Themes in Cell–Cell Junctions and Cell Adhesion
R Eelkema, P Cowin |
Tight Junctions | 2001 |
Immunofluorescence in dermatology
DF Mutasim, BB Adams |
Journal of the American Academy of Dermatology | 2001 |
Immunology, Immunopathology, and Immunity
S Sell |
2001 | |
Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions in neonatal mice
Vu Thuong Nguyen, Assane Ndoye, Leonard D. Shultz, Mark R. Pittelkow, Sergei A. Grando |
Journal of Clinical Investigation | 2000 |
In Vitro and In Vivo Expression of Interleukin-1alpha and Tumor Necrosis Factor-alpha mRNA in Pemphigus Vulgaris: Interleukin-1alpha and Tumor Necrosis Factor-alpha are Involved in Acantholysis
C Feliciani, P Toto, P Amerio, SM Pour, G Coscione, P Amerio, G Shivji, B Wang, DN Sauder |
Journal of Investigative Dermatology | 2000 |
PRESENCE OF INTERLEUKIN 10 IN THE SERUM AND BLISTER FLUID OF PATIENTS WITH PEMPHIGUS VULGARIS AND PEMPHIGOID
K Bhol |
Cytokine | 2000 |
Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity
VT Nguyen, A Ndoye, SA Grando |
The American Journal of Pathology | 2000 |
Novel Human α9 Acetylcholine Receptor Regulating Keratinocyte Adhesion is Targeted by Pemphigus Vulgaris Autoimmunity
VT Nguyen, A Ndoye, SA Grando |
The American Journal of Pathology | 2000 |
Association of KM Genotype with Bullous Pemphigoid
G Raux, D Gilbert, P Joly, M Daveau, P Martel, M Christ, F Tron |
Journal of Autoimmunity | 2000 |
Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris
MG Mahoney, Z Wang, K Rothenberger, PJ Koch, M Amagai, JR Stanley |
Journal of Clinical Investigation | 1999 |
Common Human Leukocyte Antigen Alleles in Pemphigus Vulgaris and Pemphigus Foliaceus Italian Patients
ML Lombardi, O Mercuro, V Ruocco, AL Schiavo, V Lombari, V Guerrera, G Pirozzi, C Manzo |
Journal of Investigative Dermatology | 1999 |
HLA Class II Restriction of Autoreactive T Cell Responses in Pemphigus Vulgaris: Review of the Literature and Potential Applications for the Development of a Specific Immunotherapy
R Riechers, J Grötzinger, M Hertl |
Autoimmunity | 1999 |
Pemphigus Vulgaris and Pemphigus Foliaceus Antibodies are Pathogenic in Plasminogen Activator Knockout Mice
MG Mahoney, ZH Wang, JR Stanley |
Journal of Investigative Dermatology | 1999 |
Maladies bulleuses auto-immunes
P Joly |
La Revue de Médecine Interne | 1999 |
Use of recombinant pemphigus vulgaris antigen in development of ELISA and IB assays to detect pemphigus vulgaris autoantibodies
K Bhol, S Tyagi, K Natarajan, N Nagarwalla, AR Ahmed |
Journal of the European Academy of Dermatology and Venereology | 1998 |
Potent T Cell Stimulatory Material with Antigenic Properties in Stratum Corneum of Normal Human Skin
JM Hales, RD Camp |
Journal of Investigative Dermatology | 1998 |
Affections dermatologiques de la muqueuse genitale masculine et de la verge
M Faure |
Andrologie | 1998 |
Paraneoplastic pemphigus in a dog
Lemmens, de Bruin, De Meulemeester, Wyder, Suter |
Veterinary Dermatology | 1998 |
Recurrent pemphigus vulgaris limited to the surgical area after mastectomy
S Shirahama, F Furukawa, M Takigawa |
Journal of the American Academy of Dermatology | 1998 |
The Human Complement System in Health and Disease
J Ahearn, A Rosengard |
The Human Complement System in Health and Disease | 1998 |
Novel non-radioisotope immunoprecipitation studies indicate involvement of pemphigus vulgaris antigen in paraneoplastic pemphigus
T Hashimoto, M Amagai, W Ning, T Nishikawa, T Karashima, O Mori, S Jablonska, T P Chorzelski |
Journal of Dermatological Science | 1998 |
Recognition of Desmoglein 3 by Autoreactive T Cells in Pemphigus Vulgaris Patients and Normals
M Hertl, M Amagai, H Sundaram, J Stanley, K Ishii, SI Katz |
Journal of Investigative Dermatology | 1998 |
Molecular Biological Aspects of Acquired Bullous Diseases
E Dabelsteen |
Critical Reviews in Oral Biology & Medicine | 1998 |
A Review of Methods Available for the Identification of Both Organ-Specific and Non-Organ-Specific Autoantibodies
J Miles, P Charles, P Riches |
Annals of Clinical Biochemistry | 1998 |
A complementarity-determining region peptide of an anti-desmosome autoantibody may interact with the desmosomal plaque through molecular mimicry with a cytoplasmic desmoglein 1 sequence
D Gilbert, P Courville, F Brard, P Joly, S Petit, E Bernardi, AR Schoofs, P Lauret, F Tron |
European Journal of Immunology | 1997 |
Do Certain Autoantibodies Produced in the Course of Human Autoimmune Blistering Skin Diseases Behave as Adhesion Molecules?
D Gilbert, F Brard, P Courville, P Joly, P Lauret, F Tron |
Annals of the New York Academy of Sciences | 1997 |
Oral pemphigus: Clinical significance of esophageal involvement
MD Mignogna, LL Muzio, G Galloro, RA Satriano, V Ruocco, E Bucci |
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology | 1997 |
Specific detection of anti-cell surface antibodies in herpes gestationis sera
T Hashimoto, M Amagai, H Murakami, M Higashiyama, K Hashimoto, T Nishikawa |
Experimental Dermatology | 1996 |
Pemphigus Vulgaris Antigen (Desmoglein 3) Is Localized in the Lower Epidermis, the Site of Blister Formation in Patients
M Amagai, PJ Koch, T Nishikawa, JR Stanley |
Journal of Investigative Dermatology | 1996 |
Pemphigus vulgaris in distant relatives of two families: association with major histocompatibility complex class II genes
K Bhol, J Yunis, AR Eahmed |
Clinical and Experimental Dermatology | 1996 |
The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen
K Matsumura, M Amagai, T Nishikawa, T Hashimoto |
Archives of Dermatological Research | 1996 |
Curvicircular intracytoplasmic membranous structures in keratinocytes of pemphigus foliaceus
J Tada, K Hashimoto |
Journal of Cutaneous Pathology | 1996 |
Molecular analysis of HLA DRB1 and DQB1 in Italian patients with pemphigus vulgaris
ML Lombardi, O Mercuro, G Tecame, C Fusco, V Ruocco, A Salerno, G Pirozzi, C Manzo |
Tissue Antigens | 1996 |
Altered thrombomodulin staining in blistering dermatoses
DE Jackson, CA Mitchell, G Masons, HH Salem, JA Hayman |
Pathology | 1996 |
Intramuscular gold therapy for young patients with pemphigus vulgaris: a prospective, open, clinical study utilizing a dermatologist/rheumatologist team approach
PG Sutej, JL Jorizzo, W White |
Journal of the European Academy of Dermatology and Venereology | 1995 |
In Situ-Bound Antibodies Eluted From the Skin of Patients with Bullous Pemphogoid Are Preferentially Directed Against the 230-kD Bullous Pemphigoid Antigen
NJ Korman |
Journal of Investigative Dermatology | 1995 |
Antigen-Specific Immunoadsorption of Pathogenic Autoantibodies in Pemphigus Foliaceus
M Amagai, T Hashimoto, KJ Green, N Shimizu, T Nishikawa |
Journal of Investigative Dermatology | 1995 |
Autoantibodies to desmoplakin I and II in patients with erythema multiforme
D Foedinger, GJ Anhalt, B Boecskoer, A Elbe, K Wolff, K Rappersberger |
Journal of Experimental Medicine | 1995 |
Adhesion Molecules. I: Keratinocyte-Keratinocyte Interactions; Cadherins and Pemphigus
M Amagai |
Journal of Investigative Dermatology | 1995 |
Study on an antibody against F1F2 fragment of human factor V in a patient with Hashimoto's disease and bullous pemphigoid
E Suehisa, M Toku, N Akita, R Fushimi, T Takano, H Tada, Y Iwatani, N Amino |
Thrombosis Research | 1995 |
Atypical pemphigus associated with monoclonal IgA gammopathy
S Miyagawa, T Hashimoto, H Ohno, A Nakagawa, K Watanabe, T Nishikawa, T Shirai |
Journal of the American Academy of Dermatology | 1995 |
Interferon--mediated Inactivation of Transcription of the 230-kDa Bullous Pemphigoid Antigen Gene (BPAG1) Provides Novel Insight into Keratinocyte Differentiation
K Tamai, K Li, S Silos, L Rudnicka, T Hashimoto, T Nishikawa, J Uitto |
The Journal of biological chemistry | 1995 |
Tissue-specific Expression of the 230-kDa Bullous Pemphigoid Antigen Gene ( BPAG1 ): IDENTIFICATION OF A NOVEL KERATINOCYTE REGULATORY cis -ELEMENT KRE3
K Tamai, SA Silos, K Li, E Korkeela, H Ishikawa, J Uitto |
The Journal of biological chemistry | 1995 |
The epidermolytic (exfoliative) toxins of Staphylococcus aureus
CJ Bailey, BP Lockhart, MB Redpath, TP Smith |
Medical Microbiology and Immunology | 1995 |
Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus
M Amagai, T Hashimoto, N Shimizu, T Nishikawa |
Journal of Clinical Investigation | 1994 |
Mouse 230-kDa Bullous Pemphigoid Antigen Gene: Structural and Functional Characterization of the 5'-Flanking Region and Interspecies Conservation of the Deduced Amino-Terminal Peptide Sequence of the Protein
D Sawamura, T Sato, A Kon, K Harada, K Nomura, I Hashimoto, K Tamai, J Uitto |
Journal of Investigative Dermatology | 1994 |
HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanesepemphigus vulgarispatients by the PCR-RFLP method
H Niizeki, H Inoko, N Mizuki, N Inamoto, K Watababe, T Hashimoto, T Nishikawa |
Tissue Antigens | 1994 |
Overlapping Distribution of Autoantibody Specificities in Paraneoplastic Pemphigus and Pemphigus Vulgaris
P Joly, E Thomine, D Gilbert, S Verdier, A Delpech, C Prost, C Lebbe, P Lauret, F Tron |
Journal of Investigative Dermatology | 1994 |
Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris
A Firooz, A Mazhar, AR Ahmed |
Journal of the American Academy of Dermatology | 1994 |
Childhood bullous pemphigoid: Immunohistochemical, immunoelectron microscopic, and Western blot analysis
T Nagano, M Tani, A Adachi, T Takanaga, S Sakamoto, S Kodama, S Fujiwara |
Journal of the American Academy of Dermatology | 1994 |
Autoantibodies against Cell Adhesion Molecules in Pemphigus
M Amagai |
The Journal of Dermatology | 1994 |
Pemphigus Vulgaris Associated with Autoimmune Hemolytic Anemia and Elevated TNFα
M Ujihara, S Hamanaka, S Matsuda, F Numa, H Kato |
The Journal of Dermatology | 1994 |
Expression of laminin, type IV procollagen and 230 kDa bullous pemphigoid antigen genes by keratinocytes and fibroblasts in culture: application of the polymerase chain reaction for detection of small amounts of messenger RNA
K Nomura, T Sugawara, T Sato, D Sawamura, I Hashimoto, Y Sugita, J Uitto |
Archives of Dermatological Research | 1994 |
Identification of a DNA-binding protein (keratinocyte transcriptional protein-1) recognizing a keratinocyte-specific regulatory element in the 230-kDa bullous pemphigoid antigen gene
K Tamai, K Li, J Uitto |
The Journal of biological chemistry | 1994 |
PHYSICALLY INDUCED PEMPHIGUS AFTER COSMETIC PROCEDURES
RP Kaplan, SP Detwiler, HW Saperstein |
International Journal of Dermatology | 1993 |
Desmosomes and hemidesmosomes
DR Garrod |
Current Opinion in Cell Biology | 1993 |
Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes
S Kárpáti, M Amagai, R Prussick, K Cehrs, JR Stanley |
The Journal of Cell Biology | 1993 |
Immunofluorescence and Immunoelectron Microscopy Analyses of a Human Monoclonal Anti-Epithelial Cell Surface Antibody that Recognizes a 185-kD Polypeptide: A Component of the Paraneoplastic Pemphigus Antigen Complex?
P Joly, D Gilbert, E Thomine, A Delpech, S Verdier, P Lauret, F Tron |
Journal of Investigative Dermatology | 1993 |
IgG Antibodies from Patients with Bullous Pemphigoid Bind to Fusion Proteins Encoded by BPAg1 cDNA
JE Miller, MJ Rico, RP Hall |
Journal of Investigative Dermatology | 1993 |
Cellular origin of the dermal-epidermal basement membrane
MP Marinkovich, DR Keene, CS Rimberg, RE Burgeson |
Developmental Dynamics | 1993 |
Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma
M Rybojad, T Leblanc, B Flageul, P Bernard, P Morel, G Schaison, MF D'agay, L Borrador |
British Journal of Dermatology | 1993 |
PEMPHIGUS VULGARIS ASSOCIATED WITH SPINDLE CELL THYMOMA
DL Norris, MS Saywell, GM Strutton, GJ Stephenson |
Australasian Journal of Dermatology | 1993 |
Skin diseases
BR Hughes |
Reviews in Clinical Gerontology | 1993 |
Pathology of Domestic Animals
IK Barker, AV Dreumel, N Palmer |
Pathology of Domestic Animals | 1993 |
Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines
A Mohimen, R Neumann, CS Foster, AR Ahmed |
Current Eye Research | 1993 |
Non-Infectious Diseases of the Oral Soft Tissue: a New Approach
DM Williams |
Advances in dental research | 1993 |
Inherited Epidermolysis Bullosa: Clinical Features, Molecular Genetics, and Pathoetiologic Mechanisms
J Uitto, AM Christiano |
Dermatologic Clinics | 1993 |
Drug-Induced Pemphigus
DF Mutasim, NJ Pelc, GJ Anhalt |
Dermatologic Clinics | 1993 |
Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5‘-end of the gene and the 3‘-untranslated region of the mRNA
K Li, K Tamai, EM Tan, J Uitto |
The Journal of biological chemistry | 1993 |
Human autoantibodies against desmoplakins in paraneoplastic pemphigus
JR Oursler, RS Labib, L Ariss-Abdo, T Burke, EJ O'Keefe, GJ Anhalt |
Journal of Clinical Investigation | 1992 |
Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases
J Uitto, AM Christiano |
Journal of Clinical Investigation | 1992 |
Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic
M Amagai, S Karpati, R Prussick, V Klaus-Kovtun, JR Stanley |
Journal of Clinical Investigation | 1992 |
Immunomorphologic and Biochemical Identification of the Pemphigus Foliaceous Autoantigen Within Desmosomes
K Rappersberger, N Roos, JR Stanley |
Journal of Investigative Dermatology | 1992 |
230-kD and 180-kD Bullous Pemphigoid Antigens Are Distinct Gene Products
D Saweamura, DK Li, J Uitto |
Journal of Investigative Dermatology | 1992 |
The biology and clinical application of systemic glucocorticoids
SR Feldman |
Current Problems in Dermatology | 1992 |
Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy
PJ Lamey, TD Rees, WH Binnie, JM Wright, KV Rankin, NB Simpson |
Oral Surgery, Oral Medicine, Oral Pathology | 1992 |
The Autoimmune Diseases II
CC Bernard, TE Mandel, IR Mackay |
The Autoimmune Diseases II | 1992 |
The interleukin-2 receptor in lesions and serum of bullous pemphigoid
D Zillikens, A Ambach, M Schuessler, R Dummer, AA Hartmann, G Burg |
Archives of Dermatological Research | 1992 |
Recent advances on the 180-kDa epidermal antigen in autoimmune subepidermal bullous skin diseases
P Bernard |
Springer Seminars in Immunopathology | 1992 |
Structure and antigenicity of the skin basement membrane zone
JD Fine |
Journal of Cutaneous Pathology | 1991 |
Bullous Pemphigoid Antigen: cDNA Cloning, Cellular Expression, and Evidence for Polymorphism of the Human Gene
D Sawamura, KH Li, K Nomura, Y Sugita, AM Christiano, J Uitto |
Journal of Investigative Dermatology | 1991 |
Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes
WG Carter, MC Ryan, PJ Gahr |
Cell | 1991 |
HLA class II antigens are associated with Japanese pemphigus patients
H Niizeki, H Inoko, H Narimatsu, H Takata, A Sonoda, T Tadakuma, A Ando, K Tsuji, T Hashimoto, T Nishikawa |
Human Immunology | 1991 |
Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins
T Tanaka, DA Parry, V Klaus-Kovtun, PM Steinert, JR Stanley |
The Journal of biological chemistry | 1991 |
The role of ligand-receptor interactions in disease
BJ Vermeer, JA Leuven |
Journal of Dermatological Science | 1990 |
Dermatology
MH Rustin |
Postgraduate medical journal | 1990 |
Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes
WG Carter, P Kaur, SG Gil, PJ Gahr, EA Wayner |
The Journal of Cell Biology | 1990 |
Vesiculobullous mucocutaneous disease: pemphigus vulgaris
DM Williams |
Journal of Oral Pathology and Medicine | 1989 |
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson |
1988 |